[Treatment of non-renal anemia with human recombinant erythropoietin (rHU-EPO].
The paper summarises updated knowledge concerning use of rHuEPO in patients with non-renal anemia. Taking into consideration hematological and clinical effects as well as improvement of general well-being obtained after EPO treatment, administration of this hormone is an essential extension of indication for this type of patients.